Concepedia

R Hahn

RH

Statistics

Publications

28

Citations

1.1K

H-Index

19

Active since

1966

Affiliations

Eli Lilly (United States)(Current)

The Ohio State University

R Hahn is an author at Eli Lilly (United States) specializing in medicine, pharmacology, and neuropharmacology.

Publications per year

1966–1992

28

Publications

28

Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist.

R Hahn, J. R. JUN. WARDELL, Henry M. Sarau et al. · PubMed · 1982 · 205 citations

, , +14

Resolution and absolute configuration of an ergoline-related dopamine agonist, trans-4,4a,5,6,7,8,8a,9-octahydro-5-propyl-1H(or 2H)-pyrazolo[3,4-g]quinoline

Robert D. Titus, Edmund C. Kornfeld, Noel D. Jones et al. · Journal of Medicinal Chemistry · 1983 · 121 citations · Full text

, , +15

Absolute stereochemistry and dopaminergic activity of enantiomers of 2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine

Carl Kaiser, Penelope A. Dandridge, Eleanor Garvey et al. · Journal of Medicinal Chemistry · 1982 · 82 citations · Full text

, , +15

Separation of potent central and renal dopamine agonist activity in substituted 6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepines

Joseph Weinstock, James W. Wilson, David L. Ladd et al. · Journal of Medicinal Chemistry · 1980 · 73 citations

, , +6

Dopaminergic activity of substituted 6-chloro-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines

Francis R. Pfeiffer, James W. Wilson, Joseph Weinstock et al. · Journal of Medicinal Chemistry · 1982 · 61 citations

, , +15

1–5 of 28